In fact, LUCAT1 has been found to be upregulated in multiple cancers, including non-small-cell lung carcinoma (NSCLC), esophageal cancer, renal cell carcinoma, and osteosarcoma [48,50,51,52,53,54]. Here, LUCAT1 is linked to renal cell carcinoma.